Qingdao University
Also known as: 7.The Affiliated Hospital of Qingdao University | Affiliated hospital of Qingdao University | Affiliated Hospital of Qingdao University | Cao Yu | Hospital of Qingdao University | Liangzhou Wei | Qingdao University | Qingdao University Hospital | The Affiliated Hospital of Medical College of Qingdao University | The Affiliated Hospital of Qingdao University | The Affiliated Hospital of Qingdao University Phase I Clinical Research Center | The affilited hospital of medical college,Qingdao university | the study director of phase I clinical research center | wangdabo | Yantai City Hospital for Infectious Diseases | Yantai City Hospital for Infectious Diseases Immunotherapy center | Yantai Infectious Diseases Hospital | Yantai Yuhuangding Hospital
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2006Last known activity
Nov 30, 2025
Timeline
1900s
- Jan 1, 1909
Qingdao University— Founded
Drugs by trial phase (217 distinct, 174 trials)
Phase 4 (54 own, 0 via acquisition)
Phase 3 (40 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (45 own, 0 via acquisition)
Other trials (33 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Aplastic
- Arteriosclerosis
- Arteriosclerosis Obliterans
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Cerebral Infarction
- Colitis
- Colitis, Ulcerative
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetic Foot
- Digestive System Neoplasms
- Embolism
- Esophageal Neoplasms
- Fibrosis
- Gastrointestinal Neoplasms
- Gastroparesis
- Glioma
- Gout
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hepatoblastoma
- Hyperphosphatemia
- Hypertension
- Hypertension, Portal
- Hypertension, Pulmonary
- Immunoblastic Lymphadenopathy
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Malnutrition
- May-Thurner Syndrome
- Neoplasms
- Neuroblastoma
- Neurotoxicity Syndromes
- Neutropenia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Embolism
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency, Chronic
- Retinoblastoma
- Small Cell Lung Carcinoma
- Stroke
- Thrombocytopenia
- Thromboembolism
- Thrombosis
- Ulcer
- Venous Thromboembolism
- Venous Thrombosis
Recent trials (50)
- NCT07239674CollaboratorPhase 3Nov 30, 2025
- NCT07167342OfficialPhase 4Oct 31, 2025
- NCT07167342Sponsor investigatorPhase 4Oct 31, 2025
- NCT07152886Sponsor investigatorPhase 4Oct 31, 2025
- NCT07167342CollaboratorPhase 4Oct 31, 2025
- NCT07152886Lead sponsorPhase 4Oct 31, 2025
- NCT07152886OfficialPhase 4Oct 31, 2025
- NCT07167342Lead sponsorPhase 4Oct 31, 2025
- NCT07152886CollaboratorPhase 4Oct 31, 2025
- NCT07054242Sponsor investigatorPhase 2Oct 30, 2025
- NCT07054242Lead sponsorPhase 2Oct 30, 2025
- NCT07157631CollaboratorN/ASep 29, 2025
- NCT06902740CollaboratorPhase 4Sep 1, 2025
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT06880939CollaboratorN/AJul 15, 2025
Details
- Founded
- Qingdao, CN Jan 1, 1909
- Last known activity
- Nov 30, 2025